Study of Brexucabtagene Autoleucel Plus Dasatinib in Adults With Acute Lymphoblastic Leukemia
Condition: Lymphoblastic Leukemia Intervention: Drug: Dasatinib Sponsors: Stanford University; Kite Pharma Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Leukemia | Pharmaceuticals | Research | Study